The latest closing stock price for Trevi Therapeutics as of November 20, 2024 is 2.77.
An investor who bought $1,000 worth of Trevi Therapeutics stock at the IPO in 2019 would have $-649 today, roughly -1 times their original investment - a -16.01% compound annual growth rate over 6 years.
The all-time high Trevi Therapeutics stock closing price was 10.12 on June 03, 2019.
The Trevi Therapeutics 52-week high stock price is 4.00, which is 44.4% above the current share price.
The Trevi Therapeutics 52-week low stock price is 0.97, which is 65% below the current share price.
The average Trevi Therapeutics stock price for the last 52 weeks is 2.58.
An investor who bought $1,000 worth of Trevi Therapeutics stock at the IPO in 2019 would have $-649 today, roughly -1 times their original investment - a -16.01% compound annual growth rate over 6 years.
The all-time high Trevi Therapeutics stock closing price was 10.12 on June 03, 2019.
The Trevi Therapeutics 52-week high stock price is 4.00, which is 44.4% above the current share price.
The Trevi Therapeutics 52-week low stock price is 0.97, which is 65% below the current share price.
The average Trevi Therapeutics stock price for the last 52 weeks is 2.58.